Within this role, I had the opportunity to own and prioritise the product back log for AI (NLG) products to facilitate the delivery of automated financial and clinical study reports directly consumed from c-suite board members to senior finance and clinical directors. I also acted as change lead for data product adoption across global financial reporting tools.